Asymmetric dimethylarginine (ADMA) has been shown to be an independent predictor of
cardiovascular diseases. Dimethylarginine dimethylaminohydrolase 2 (DDAH 2) promotes …

AIMS: The aim of this study was to investigate whether the polymorphism of DDAH2 is
associated with type 2 diabetes and hypertension in Korean population. METHODS: Total …

Objective: To examine whether the DDAH2 promoter polymorphisms-1415G/A (rs2272592),-
1151A/C (rs805304) and-449G/C (rs805305), and their haplotypes, are associated with PE …

Cerebrovascular endothelial dysfunction is involved in the progression of leukoaraiosis.
Asymmetric dimethylarginine is a competitive inhibitor of nitric oxide, which is highly …

This study investigated the role of the T-786C polymorphism (SNP) in the 5'-flanking
sequence of the endothelial nitric oxide synthase gene (eNOS) on its expression level in …

The purpose of the present study was to establish the role of DDAH gene polymorphisms in
the risk of developing myocardial infarction (MI) in a clinical cohort of Mexican patients. One …

摘要目的: 研究DDAH2 启动子区-1150 C/A rs805304 多态性与中国汉族人群冠心病之间的相关
性. 方法: 应用限制性片段长度多态性聚合酶链反应(PCR-RFLP) 的分析方法, 对381 …

脑血管内皮功能障碍参与了白质病变的进展. 不对称二甲基精氨酸是一氧化氮的竞争性抑制剂,
可在脑白质疏松患者中高表达. 二甲精氨酸二甲胺水解酶是一种水解酶, 可负责消除不对称二甲 …

Objective: Globally developing metabolic syndrome (MetS) prevalence as a major health
problem can be related to multiple factors of genetic and environmental …

Cardiovascular disease (CVD) remains the leading cause of death worldwide. Despite huge
efforts and great advances in studying the genetic component of CVD, there is still a great …